Genomics England, a company wholly owned and funded by the Department of Health & Social Care, was set up to deliver this flagship project which will sequence 100,000 whole genomes from NHS patients. Its four main aims are; to create an ethical and transparent programme based on consent; to bring benefit to patients and set up a genomic medicine service for the NHS; to enable new scientific discovery and medical insights; and to kick start the development of a UK genomics industry.

This project is an important and exciting research area:

The Cure Parkinson’s Trust is a keen supporter of the 100,000 genome project. More and more we are seeing how the combining of genomic sequence data with medical records is proving to be a ground-breaking resource.  Genomics has already started to guide and inform doctors about the best treatment for individual patients. If we can forecast how well a person will respond to a treatment or determine what will work best for them – so called personalised medicine – this will be of huge benefit to people living with Parkinsons now and in the future.

Thank you to everyone who has participated in the 100,000 Genomes Project which has now reached full capacity. 

Find out more about this study here: